GSK vs WPC · P/E 13, $103.31B cap vs P/E 44, rev $915.6M
GlaxoSmithKline PLC ADR (GSK) versus W P Carey Inc (WPC) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
W P Carey Inc (WPC) is a reit - diversified company listed on US.
GSK does not have a complete income-statement cache yet.
Latest reported WPC revenue for 2026-06-30 was $915.6M. Net income was $361.7M. WPC currently screens at market cap $14.69B and trailing P/E 44.1.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. WPC currently screens at market cap $14.69B and trailing P/E 44.1.
Not investment advice. Open the GSK and WPC stock pages for the full models.
Not investment advice.